Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2021 Jun 5;189(1):145–154. doi: 10.1007/s10549-021-06284-7

Table 2.

Change in body composition by randomized group

Endpoint Randomized
Group
Baseline
Mean (SD)
52 Week
Mean Change (SE)
Estimated Treatment
Difference (95% CI)
Body weight, kg Control 89.3 (16.9) −0.27 (0.63) 0.00—Reference
Exercise 89.7 (16.2) −0.33 (0.66) −0.06 (−1.85, 1.72)
Diet 89.9 (16.5) −5.66 (0.69)a −5.39 (−7.24, −3.55)b
Exercise & Diet 91.2 (16.3) −6.95 (0.67)a −6.68 (−8.46, −4.90)b
Fat mass, kg Control 40.9 (10.7) −0.94 (0.51) 0.00—Reference
Exercise 40.3 (10.9) −0.79 (0.52) 0.14 (−1.30, 1.59)
Diet 40.6 (10.3) −4.52 (0.52)a −3.59 (−5.00, −2.17)b
Exercise & Diet 41.7 (10.2) −5.22 (0.53)a −4.28 (−5.71, −2.84)b
Visceral adipose tissue, cm2 Control 158.6 (57.2) −6.59 (3.63) 0.00—Reference
Exercise 164.8 (75.5) −12.09 (3.90)a −5.50 (−15.73, 4.73)
Diet 158.2 (62.2) −27.87 (3.68)a −21.28 (−31.37, −11.19)b
Exercise & Diet 155.0 (69.6) −26.46 (3.67)a −19.87 (−30.03, −9.70)b
Subcutaneous adipose tissue, cm2 Control 515.2 (128.0) −5.05 (7.17) 0.00—Reference
Exercise 491.9 (133.2) 2.64 (7.16) 7.69 (−12.20, 27.58)
Diet 507.2 (125.9) −44.59 (7.40)a −39.53 (−59.85, −19.23)b
Exercise & Diet 502.7 (136.1) −50.24 (7.46)a −45.19 (−65.14, −25.23)b
Lean mass, kg Control 49.1 (7.6) −0.06 (0.25) 0.00—Reference
Exercise 50.1 (6.6) 0.36 (0.25) 0.42 (−0.25, 1.10)
Diet 49.9 (7.3) −0.88 (0.24)a −0.82 (−1.50, −0.15)b
Exercise & Diet 50.4 (7.3) −1.30 (0.24)a −1.24 (−1.92, −0.56)b
Appendicular lean mass, kg Control 21.4 (3.8) −0.05 (0.11) 0.00—Reference
Exercise 22.2 (3.7) 0.18 (0.11) 0.23 (−0.08, 0.54)
Diet 22.0 (3.8) −0.37 (0.11)a −0.32 (−0.63, −0.01)b
Exercise & Diet 22.3 (3.8) −0.51 (0.11)a −0.46 (−0.77, −0.15)b
Bone mineral density, g/cm2 Control  1.12 (0.12) −0.007 (0.004) 0.000—Reference
Exercise  1.12 (0.13) −0.007 (0.004) −0.001 (−0.012, 0.010)
Diet  1.16 (0.13) −0.002 (0.004) 0.005 (−0.006, 0.016)
Exercise & Diet  1.15 (0.14) −0.003 (0.004) 0.003 (−0.008, 0.014)

Note: Unobserved data were multiply imputed using predictive mean matching and analyzed using a repeated measures analysis of covariance model. Models are adjusted for the baseline value of the dependent variable, and randomization stratification factors including age, receipt of radiotherapy, number of lymph nodes resected, lymphedema severity, and body mass index.

a

P<0.05 (two-sided) compared with baseline (within group).

b

P<0.05 (two-sided) compared with control, adjusted for multiplicity.